118 -11 (73) 2024 - Boymuradov Sh.A., Ruzieva S.S. - STUDY OF CLINICAL AND LABORATORY CHARACTERISTICS OF MAXILLOFACIAL DEFECTS IN PATIENTS WITH COVID-19

STUDY OF CLINICAL AND LABORATORY CHARACTERISTICS OF MAXILLOFACIAL DEFECTS IN PATIENTS WITH COVID-19

Boymuradov Sh.A. - Tashkent Medical Academy

Ruzieva S.S. - Tashkent Medical Academy

Babamuratova B.T.. - Tashkent Medical Academy

Iminov K.O. - Tashkent Medical Academy

Resume

The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has led to a huge numbers of complications, which can influence the respiratory system of human. Nowadays maxillofacial defects are diagnosed by healthcare system more often then, period until COVID-19 pandemic. This article purposes are research the clinical and laboratory features, which determined with maxillofacial defects in after COVID-19 patients, a comprehensive researches about early diagnosis and effective management of this issue were conducted by our study group.

Key words: maxillofacial defects, covid-19,сlinical characteristics, laboratory characteristics, oral health

First page

681

Last page

686

For citation:Boymuradov Sh.A., Ruzieva S.S., Babamuratova B.T., Iminov K.O. - STUDY OF CLINICAL AND LABORATORY CHARACTERISTICS OF MAXILLOFACIAL DEFECTS IN PATIENTS WITH COVID-19//New Day in Medicine 11(73)2024 681-686 https://https://newdayworldmedicine.com/en/new_day_medicine/11-73-2024

List of References

1. World Health Organization. (2021). COVID-19 Weekly Epidemiological Update.
2. Mehta, S., & Pandey, A. (2020). Rhino-Orbital Mucormycosis Associated With COVID-19. Cureus, 12(9), e10726.
3. Sen, M., Honavar, S. G., Bansal, R., et al. (2021). Epidemiology, Clinical Profile, Management, and Outcome of COVID-19-associated Rhino-Orbital-Cerebral Mucormycosis in 2826 Patients in India. Ophthalmology, 128(11), 1667-1676.
4. Rocha BA, Souto GR, Grossmann SMC, Aguiar MCF, Andrade BAB, Roma˜ nach MJ,Horta MCR. Viral enanthema in oral mucosa: a possible diagnostic challenge in the COVID-19 pandemic. Oral Dis 2021. https://doi.org/10.1111/odi.13473.
5. Carreras-Presas CM, S´ anchez JA, L´ opez-S´ anchez AF, Jan´ e-Salas E, P´erez MLS. Oral vesiculobullous lesions associated with SARS-CoV-2 infection. Oral Dis 2021;3(27): 710 https://doi.org/10.1111/odi.13382. 10.1111/odi.13382.
6. Chaux-Bodard AG, Deneuve S, Desoutter A. Oral manifestation Covid-19 as aninaugural symptom? J Oral Med Oral Surg 2020;26(2):18.
7. Martín Carreras-Presas C, Amaro S´ anchez J, L´ opezS´ anchez AF, Jan´ e-Salas E,Somacarrera P´erez ML. Oral vesiculobullous lesions associated with SARS-CoV-2infection. Oral Dis. 2020.
8. Rehman A, Bello IO, Apu EH. Oral lesions in the COVID-19 positive individuals –an update. Arch Dent 2020;2(1):8–9.

   file

   download